Can hormones rewrite the very blueprint of our DNA?

Health · Published 19 October 2026 Swipe more like this →

In short: Beyond altering physical features, recent molecular research suggests gender-affirming hormone therapy may actually shift the epigenetic landscape of our cells. These biological changes can move genetic expression to more closely match an individual's affirmed gender, potentially even silencing certain genes linked to health conditions like breast cancer.

Gender-affirming hormone therapy (GAHT) uses sex hormones and other medications to align secondary sexual characteristics with gender identity. For those seeking masculinization, treatment typically involves androgens and occasionally antiestrogens. Feminizing therapy often utilizes estrogens, sometimes paired with antiandrogens to suppress testosterone, promoting changes like breast development and fat redistribution.

Recent molecular biology research highlights a profound internal shift. A 2022 analysis found that GAHT influences gene expression, with researchers observing changes to the epigenetic landscape of DNA. Notably, areas displaying sex-based differences prior to hormone therapy steadily moved towards the affirmed gender's pattern following a year of treatment. A 2023 study on breast tissue in transgender men even found that adding androgens appeared to silence certain genes, including those linked to breast cancer.

While these biological shifts are significant, the therapy's impact on all physical structures remains a subject of study. A retrospective study using CT imaging of 12 adult transgender individuals found no significant differences in the cross-sectional areas of large conducting airways after at least one year of feminizing therapy. This suggests that while cellular landscapes may shift, some structural elements, like airway size, might remain unchanged.

The medical landscape is also evolving. Many institutions are moving away from historical 'gatekeeping'—such as requiring 'real-life experience' or lengthy psychiatric evaluations—toward an informed consent model. This model focuses on ensuring patients understand the risks and benefits, such as potential impacts on fertility or cardiovascular health, rather than requiring a formal diagnosis of gender dysphoria as a prerequisite for all care.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Is gender defined by DNA alone, or can life experiences rewrite our biology?
• How social experience physically rewires the expression of your DNA
• The biological and social puzzle of gender identity
• How hormone replacement therapy works
• Every estrogen in your body starts life as an androgen like testosterone
• Why Britain's highest-paid entertainer was rejected for military service during the Second World War
• Basal ganglia are not ganglia in the modern sense
• Water holds little oxygen, so gills must be huge surfaces
• Furosemide: The Water Tablet That Keeps Millions of Hearts and Kidneys Functioning Daily
• Some glands destroy their own cells to release oil
• Fur length alone does not decide how warm a coat is
• The gut hormone behind today's weight-loss drugs survives about two minutes

More in Anatomy and morphology · More in Health · Latest · A–Z · All topics